h&e staining Search Results


96
MedChemExpress sting inhibitor h151
Sting Inhibitor H151, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sting inhibitor h151/product/MedChemExpress
Average 96 stars, based on 1 article reviews
sting inhibitor h151 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

99
Hitachi Ltd tem
Tem, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tem/product/Hitachi Ltd
Average 99 stars, based on 1 article reviews
tem - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

96
MedChemExpress hoechst 33342 reagent
Hoechst 33342 Reagent, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hoechst 33342 reagent/product/MedChemExpress
Average 96 stars, based on 1 article reviews
hoechst 33342 reagent - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

97
New England Biolabs endo β n acetylglucosaminidase h
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Endo β N Acetylglucosaminidase H, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endo β n acetylglucosaminidase h/product/New England Biolabs
Average 97 stars, based on 1 article reviews
endo β n acetylglucosaminidase h - by Bioz Stars, 2026-04
97/100 stars
  Buy from Supplier

98
New England Biolabs rnase h treatment
Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.
Rnase H Treatment, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rnase h treatment/product/New England Biolabs
Average 98 stars, based on 1 article reviews
rnase h treatment - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mif shrna lentiviral particle infection
(a) Representative images and quantification of pre-metastatic niche markers in livers educated with PAN02 exosomes (Exo), PAN02shCTL exosomes (shCTLexo), PAN02shMIF exosomes (shMIFexo and shMIF(2)exo) or PBS control (CTL). Immunofluorescence analysis shows frequency of TGFβ-expressing F4/80+ cells, αSMA and FN expression as well as F4/80+ cell frequency. Inset shows TGFβ+/F4/80+ cell; n = 3 (CTL F4/80), n = 4 (CTL TGFβ, αSMA, FN; Exo TGFβ; all shCTL; shMIF TGFβ; all shMIF(2), n = 6 (Exo F4/80; shMIF F4/80), n = 7 (Exo αSMA, FN; shMIF αSMA, FN) mice pooled from two experiments. ***P < 0.001, **P < 0.001 by ANOVA. Scale bars, 100μm. (b) Evaluation of liver metastasis by liver weight (grams) in tumor-free mice (CTL), mice injected intra-splenically with PAN02 cells either pre-educated with PBS (TU), with PAN02 exosomes (Exo+TU), with PAN02 exosomes in combination with A83-01 (Exo+A83-01+TU), or with PAN02shMIF exosomes (shMIFexo+TU); n = 4 (Exo+A83-01+TU), n = 5 (CTL, TU, Exo+TU, and shMIFexo+TU) mice pooled from two experiments. **P < 0.01, *P < 0.05 by ANOVA. Scale bar, 1cm. (c) Evaluation of liver metastasis in mice injected intra-splenically with PAN02 cells either pre-educated with PBS (TU), with exosomes isolated from PAN02 cells infected with control <t>shRNA</t> (shCTLexo+TU) or shMIF(2) (shMIF(2)exo+TU) <t>lentiviral</t> vectors; n = 4 (shCTLexo+TU), n = 5 (shMIF(2)exo+TU) and n = 6 (TU) mice from one experiment. ***P < 0.01 by ANOVA. Scale bar, 1cm. (d) Enzyme-linked immune assay (ELISA) reveals increased levels of <t>MIF</t> (picogram per 108 exosomes) in exosomes isolated from patients with pancreatic ductal adenocarcinoma (PDAC) with progression of disease post-diagnosis (POD) compared to PDAC patients with no evidence of disease 5 years post-diagnosis (NED) and to healthy controls (CTL), but not PDAC patients with liver metastasis (LM); n = 10 (NED), n = 12 (POD), n = 15 (CTL) and n = 18 (LM) patients. All patient samples were analyzed once as part of three independent ELISA assays. **P < 0.01 by ANOVA. All data are represented as mean±s.e.m
Mif Shrna Lentiviral Particle Infection, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mif shrna lentiviral particle infection/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
mif shrna lentiviral particle infection - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology h cald
(a) Representative images and quantification of pre-metastatic niche markers in livers educated with PAN02 exosomes (Exo), PAN02shCTL exosomes (shCTLexo), PAN02shMIF exosomes (shMIFexo and shMIF(2)exo) or PBS control (CTL). Immunofluorescence analysis shows frequency of TGFβ-expressing F4/80+ cells, αSMA and FN expression as well as F4/80+ cell frequency. Inset shows TGFβ+/F4/80+ cell; n = 3 (CTL F4/80), n = 4 (CTL TGFβ, αSMA, FN; Exo TGFβ; all shCTL; shMIF TGFβ; all shMIF(2), n = 6 (Exo F4/80; shMIF F4/80), n = 7 (Exo αSMA, FN; shMIF αSMA, FN) mice pooled from two experiments. ***P < 0.001, **P < 0.001 by ANOVA. Scale bars, 100μm. (b) Evaluation of liver metastasis by liver weight (grams) in tumor-free mice (CTL), mice injected intra-splenically with PAN02 cells either pre-educated with PBS (TU), with PAN02 exosomes (Exo+TU), with PAN02 exosomes in combination with A83-01 (Exo+A83-01+TU), or with PAN02shMIF exosomes (shMIFexo+TU); n = 4 (Exo+A83-01+TU), n = 5 (CTL, TU, Exo+TU, and shMIFexo+TU) mice pooled from two experiments. **P < 0.01, *P < 0.05 by ANOVA. Scale bar, 1cm. (c) Evaluation of liver metastasis in mice injected intra-splenically with PAN02 cells either pre-educated with PBS (TU), with exosomes isolated from PAN02 cells infected with control <t>shRNA</t> (shCTLexo+TU) or shMIF(2) (shMIF(2)exo+TU) <t>lentiviral</t> vectors; n = 4 (shCTLexo+TU), n = 5 (shMIF(2)exo+TU) and n = 6 (TU) mice from one experiment. ***P < 0.01 by ANOVA. Scale bar, 1cm. (d) Enzyme-linked immune assay (ELISA) reveals increased levels of <t>MIF</t> (picogram per 108 exosomes) in exosomes isolated from patients with pancreatic ductal adenocarcinoma (PDAC) with progression of disease post-diagnosis (POD) compared to PDAC patients with no evidence of disease 5 years post-diagnosis (NED) and to healthy controls (CTL), but not PDAC patients with liver metastasis (LM); n = 10 (NED), n = 12 (POD), n = 15 (CTL) and n = 18 (LM) patients. All patient samples were analyzed once as part of three independent ELISA assays. **P < 0.01 by ANOVA. All data are represented as mean±s.e.m
H Cald, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h cald/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
h cald - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology human smad1 shrna
Chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) defines genome-wide transcriptional regulation by pSmad1 protein upon growth differentiation factor 15 (GDF15) in human airway epithelial cells. Normal human tracheobronchial epithelial cells in submerged culture were treated with 0.1% BSA-HCl (control) or recombinant human GDF15 (25 ng/ml) for 2 h to perform the <t>phosphorylated-Smad1</t> (pSmad1) ChIP-seq analysis.
Human Smad1 Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human smad1 shrna/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
human smad1 shrna - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology anti h ras
Chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) defines genome-wide transcriptional regulation by pSmad1 protein upon growth differentiation factor 15 (GDF15) in human airway epithelial cells. Normal human tracheobronchial epithelial cells in submerged culture were treated with 0.1% BSA-HCl (control) or recombinant human GDF15 (25 ng/ml) for 2 h to perform the <t>phosphorylated-Smad1</t> (pSmad1) ChIP-seq analysis.
Anti H Ras, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti h ras/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
anti h ras - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

93
SouthernBiotech western blottings
Chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) defines genome-wide transcriptional regulation by pSmad1 protein upon growth differentiation factor 15 (GDF15) in human airway epithelial cells. Normal human tracheobronchial epithelial cells in submerged culture were treated with 0.1% BSA-HCl (control) or recombinant human GDF15 (25 ng/ml) for 2 h to perform the <t>phosphorylated-Smad1</t> (pSmad1) ChIP-seq analysis.
Western Blottings, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/western blottings/product/SouthernBiotech
Average 93 stars, based on 1 article reviews
western blottings - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
SouthernBiotech igg2 3
(A) Experimental schema of blood collection during the immune process. (B) Total IgG antibody titres in the serum at 3, 14, 17, and 28 days after the first immunization (n = 6/group). (C) Serum IgG1 <t>and</t> <t>IgG2/3</t> titres on day 28 after immunization (n = 6/group). (D) The serum samples collected after the first and second immunizations were subjected to a microneutralization assay (MAT) using 15 standard Leptospira strains, with the data limited to those strains that exhibited agglutination (n = 6/group). (B) - (D) : PBS + VAC, orally gavaged with PBS, and vaccinated; JL20 + VAC, orally gavaged with JL20, and vaccinated. Results represent mean ± SD of values. Statistical significance was evaluated using the Wilcoxon rank-sum test, with *p < 0.05, **p < 0.01, ***p < 0.001. , created in BioRender. 603, C. (2025) https://BioRender.com/4jus9df .
Igg2 3, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/igg2 3/product/SouthernBiotech
Average 94 stars, based on 1 article reviews
igg2 3 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
SouthernBiotech alexa fluor 555 conjugated goat anti rabbit igg secondary antibody
(A) Experimental schema of blood collection during the immune process. (B) Total IgG antibody titres in the serum at 3, 14, 17, and 28 days after the first immunization (n = 6/group). (C) Serum IgG1 <t>and</t> <t>IgG2/3</t> titres on day 28 after immunization (n = 6/group). (D) The serum samples collected after the first and second immunizations were subjected to a microneutralization assay (MAT) using 15 standard Leptospira strains, with the data limited to those strains that exhibited agglutination (n = 6/group). (B) - (D) : PBS + VAC, orally gavaged with PBS, and vaccinated; JL20 + VAC, orally gavaged with JL20, and vaccinated. Results represent mean ± SD of values. Statistical significance was evaluated using the Wilcoxon rank-sum test, with *p < 0.05, **p < 0.01, ***p < 0.001. , created in BioRender. 603, C. (2025) https://BioRender.com/4jus9df .
Alexa Fluor 555 Conjugated Goat Anti Rabbit Igg Secondary Antibody, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alexa fluor 555 conjugated goat anti rabbit igg secondary antibody/product/SouthernBiotech
Average 93 stars, based on 1 article reviews
alexa fluor 555 conjugated goat anti rabbit igg secondary antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

Image Search Results


Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.

Journal: Foods

Article Title: Boosting Recombinant Bovine Chymosin in Komagataella phaffii via Fusion Protein and Constitutive Promoter Expression

doi: 10.3390/foods15040731

Figure Lengend Snippet: Purification and deglycosylation analysis of recombinant bovine chymosin. ( a ) SDS-PAGE analysis of samples from the purification process. Proteins were separated on a 12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Approximately 10 µg of protein was loaded per lane. Lane 1: Prestained protein molecular weight markers (sizes indicated on the left). Lane 2: The purified recombinant chymosin obtained after acidification activation (pH 2.5, 2 h) and subsequent concentration using a 5 kDa molecular weight cut-off (MWCO) ultrafiltration membrane. Lane 3: The culture supernatant containing the acid-activated recombinant chymosin prior to ultrafiltration. ( b ) SDS-PAGE analysis of the recombinant chymosin deglycosylation. Analysis was performed under the same conditions as in ( a ). Lane 1: Prestained protein molecular weight markers. Lane 2: Endo-β-N-acetylglucosaminidase H (Endo H) enzyme alone. Lane 3: The purified recombinant chymosin after treatment with Endo H for 2 h at 37 °C, showing the complete deglycosylated form. Lane 4: The purified recombinant chymosin without Endo H treatment, showing the glycosylated form.

Article Snippet: Endo-β-N-acetylglucosaminidase H (Endo H) was obtained from New England Biolabs (Ipswich, MA, USA).

Techniques: Purification, Recombinant, SDS Page, Staining, Molecular Weight, Activation Assay, Concentration Assay, Membrane

(a) Representative images and quantification of pre-metastatic niche markers in livers educated with PAN02 exosomes (Exo), PAN02shCTL exosomes (shCTLexo), PAN02shMIF exosomes (shMIFexo and shMIF(2)exo) or PBS control (CTL). Immunofluorescence analysis shows frequency of TGFβ-expressing F4/80+ cells, αSMA and FN expression as well as F4/80+ cell frequency. Inset shows TGFβ+/F4/80+ cell; n = 3 (CTL F4/80), n = 4 (CTL TGFβ, αSMA, FN; Exo TGFβ; all shCTL; shMIF TGFβ; all shMIF(2), n = 6 (Exo F4/80; shMIF F4/80), n = 7 (Exo αSMA, FN; shMIF αSMA, FN) mice pooled from two experiments. ***P < 0.001, **P < 0.001 by ANOVA. Scale bars, 100μm. (b) Evaluation of liver metastasis by liver weight (grams) in tumor-free mice (CTL), mice injected intra-splenically with PAN02 cells either pre-educated with PBS (TU), with PAN02 exosomes (Exo+TU), with PAN02 exosomes in combination with A83-01 (Exo+A83-01+TU), or with PAN02shMIF exosomes (shMIFexo+TU); n = 4 (Exo+A83-01+TU), n = 5 (CTL, TU, Exo+TU, and shMIFexo+TU) mice pooled from two experiments. **P < 0.01, *P < 0.05 by ANOVA. Scale bar, 1cm. (c) Evaluation of liver metastasis in mice injected intra-splenically with PAN02 cells either pre-educated with PBS (TU), with exosomes isolated from PAN02 cells infected with control shRNA (shCTLexo+TU) or shMIF(2) (shMIF(2)exo+TU) lentiviral vectors; n = 4 (shCTLexo+TU), n = 5 (shMIF(2)exo+TU) and n = 6 (TU) mice from one experiment. ***P < 0.01 by ANOVA. Scale bar, 1cm. (d) Enzyme-linked immune assay (ELISA) reveals increased levels of MIF (picogram per 108 exosomes) in exosomes isolated from patients with pancreatic ductal adenocarcinoma (PDAC) with progression of disease post-diagnosis (POD) compared to PDAC patients with no evidence of disease 5 years post-diagnosis (NED) and to healthy controls (CTL), but not PDAC patients with liver metastasis (LM); n = 10 (NED), n = 12 (POD), n = 15 (CTL) and n = 18 (LM) patients. All patient samples were analyzed once as part of three independent ELISA assays. **P < 0.01 by ANOVA. All data are represented as mean±s.e.m

Journal: Nature cell biology

Article Title: Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver

doi: 10.1038/ncb3169

Figure Lengend Snippet: (a) Representative images and quantification of pre-metastatic niche markers in livers educated with PAN02 exosomes (Exo), PAN02shCTL exosomes (shCTLexo), PAN02shMIF exosomes (shMIFexo and shMIF(2)exo) or PBS control (CTL). Immunofluorescence analysis shows frequency of TGFβ-expressing F4/80+ cells, αSMA and FN expression as well as F4/80+ cell frequency. Inset shows TGFβ+/F4/80+ cell; n = 3 (CTL F4/80), n = 4 (CTL TGFβ, αSMA, FN; Exo TGFβ; all shCTL; shMIF TGFβ; all shMIF(2), n = 6 (Exo F4/80; shMIF F4/80), n = 7 (Exo αSMA, FN; shMIF αSMA, FN) mice pooled from two experiments. ***P < 0.001, **P < 0.001 by ANOVA. Scale bars, 100μm. (b) Evaluation of liver metastasis by liver weight (grams) in tumor-free mice (CTL), mice injected intra-splenically with PAN02 cells either pre-educated with PBS (TU), with PAN02 exosomes (Exo+TU), with PAN02 exosomes in combination with A83-01 (Exo+A83-01+TU), or with PAN02shMIF exosomes (shMIFexo+TU); n = 4 (Exo+A83-01+TU), n = 5 (CTL, TU, Exo+TU, and shMIFexo+TU) mice pooled from two experiments. **P < 0.01, *P < 0.05 by ANOVA. Scale bar, 1cm. (c) Evaluation of liver metastasis in mice injected intra-splenically with PAN02 cells either pre-educated with PBS (TU), with exosomes isolated from PAN02 cells infected with control shRNA (shCTLexo+TU) or shMIF(2) (shMIF(2)exo+TU) lentiviral vectors; n = 4 (shCTLexo+TU), n = 5 (shMIF(2)exo+TU) and n = 6 (TU) mice from one experiment. ***P < 0.01 by ANOVA. Scale bar, 1cm. (d) Enzyme-linked immune assay (ELISA) reveals increased levels of MIF (picogram per 108 exosomes) in exosomes isolated from patients with pancreatic ductal adenocarcinoma (PDAC) with progression of disease post-diagnosis (POD) compared to PDAC patients with no evidence of disease 5 years post-diagnosis (NED) and to healthy controls (CTL), but not PDAC patients with liver metastasis (LM); n = 10 (NED), n = 12 (POD), n = 15 (CTL) and n = 18 (LM) patients. All patient samples were analyzed once as part of three independent ELISA assays. **P < 0.01 by ANOVA. All data are represented as mean±s.e.m

Article Snippet: MIF knockdown PAN02 cells were generated by using MIF shRNA lentiviral particle infection, generating the PAN02 variants shMIF (sc-37138-V, Santa Cruz) and shMIF(2) (iV042354, abmGood).

Techniques: Control, Immunofluorescence, Expressing, Injection, Isolation, Infection, shRNA, Enzyme-linked Immunosorbent Assay, Biomarker Discovery

Chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) defines genome-wide transcriptional regulation by pSmad1 protein upon growth differentiation factor 15 (GDF15) in human airway epithelial cells. Normal human tracheobronchial epithelial cells in submerged culture were treated with 0.1% BSA-HCl (control) or recombinant human GDF15 (25 ng/ml) for 2 h to perform the phosphorylated-Smad1 (pSmad1) ChIP-seq analysis.

Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

Article Title: Overproduction of growth differentiation factor 15 promotes human rhinovirus infection and virus-induced inflammation in the lung

doi: 10.1152/ajplung.00324.2017

Figure Lengend Snippet: Chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) defines genome-wide transcriptional regulation by pSmad1 protein upon growth differentiation factor 15 (GDF15) in human airway epithelial cells. Normal human tracheobronchial epithelial cells in submerged culture were treated with 0.1% BSA-HCl (control) or recombinant human GDF15 (25 ng/ml) for 2 h to perform the phosphorylated-Smad1 (pSmad1) ChIP-seq analysis.

Article Snippet: Lentiviruses encoding human Smad1 shRNA (sc-29483-v, shSmad1) or control shRNA (sc-108080, shControl) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

Techniques: Chromatin Immunoprecipitation, Next-Generation Sequencing, ChIP-sequencing, Genome Wide, Control, Recombinant

Overexpressing human growth differentiation factor 15 (GDF15) enhances activation of Smad1 and interferon regulatory factor 7 (IRF7) in mouse airway epithelial cells. Primary tracheal epithelial cells from naïve human GDF15 transgenic (hGDF15 Tg+) mice or wild-type (WT) littermates were grown at air-liquid interface and infected with HRV-1B [multiplicity of infection (MOI) 1] or PBS (control) for 24 h. A, left: quantitative Western blot densitometry data of phosphorylated-Smad1 (pSmad1) and total Smad1 protein. A, right: representative Western blot pictures; B, left: quantitative Western blot densitometry data of IRF7 and β-actin protein (loading control). B, right: representative Western blot pictures. Data are presented as means ± SE from three independent experiments. *P < 0.05, **P < 0.01, compared with PBS controls or HRV-infected WT cells.

Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

Article Title: Overproduction of growth differentiation factor 15 promotes human rhinovirus infection and virus-induced inflammation in the lung

doi: 10.1152/ajplung.00324.2017

Figure Lengend Snippet: Overexpressing human growth differentiation factor 15 (GDF15) enhances activation of Smad1 and interferon regulatory factor 7 (IRF7) in mouse airway epithelial cells. Primary tracheal epithelial cells from naïve human GDF15 transgenic (hGDF15 Tg+) mice or wild-type (WT) littermates were grown at air-liquid interface and infected with HRV-1B [multiplicity of infection (MOI) 1] or PBS (control) for 24 h. A, left: quantitative Western blot densitometry data of phosphorylated-Smad1 (pSmad1) and total Smad1 protein. A, right: representative Western blot pictures; B, left: quantitative Western blot densitometry data of IRF7 and β-actin protein (loading control). B, right: representative Western blot pictures. Data are presented as means ± SE from three independent experiments. *P < 0.05, **P < 0.01, compared with PBS controls or HRV-infected WT cells.

Article Snippet: Lentiviruses encoding human Smad1 shRNA (sc-29483-v, shSmad1) or control shRNA (sc-108080, shControl) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

Techniques: Activation Assay, Transgenic Assay, Infection, Control, Western Blot

Smad1 cooperates with interferon regulatory factor 7 (IRF7) in response to HRV infection via growth differentiation factor 15 (GDF15) signaling in human airway epithelial cells. A: normal human bronchial epithelial cells transduced with lentiviruses encoding human GDF15 shRNA (shGDF15) or control shRNA (shControl) were grown at air-liquid interface and infected with HRV-16 [multiplicity of infection (MOI) 1] or PBS (control) for 24 h. A, top: quantitative Western blot densitometry data of IRF7 and β-actin protein (loading control). A, bottom: representative Western blot pictures. B, top: normal human tracheobronchial epithelial cells transduced with lentiviruses encoding human Smad1 shRNA (shSmad1) or control shRNA (shControl) were grown at air-liquid interface for 28 days to examine Smad1 protein expression. B, bottom: quantitative Western blot densitometry data of Smad1 and GAPDH protein (loading control). C: normal human tracheobronchial epithelial cells transduced with lentiviruses encoding human Smad1 shRNA (shSmad1) or control shRNA (shControl) were grown at air-liquid interface, pretreated with 0.1% BSA-HCl (control) or recombinant human GDF15 (25 ng/ml) for 72 h, and infected with HRV-16 (MOI 1) or PBS for 24 h. C, top: quantitative Western blot densitometry data of IRF7 and β-actin protein (loading control). C, bottom: representative Western blot pictures. Data are presented as means ± SE from 4 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, compared with PBS controls or shControl cells; NS, not significant.

Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

Article Title: Overproduction of growth differentiation factor 15 promotes human rhinovirus infection and virus-induced inflammation in the lung

doi: 10.1152/ajplung.00324.2017

Figure Lengend Snippet: Smad1 cooperates with interferon regulatory factor 7 (IRF7) in response to HRV infection via growth differentiation factor 15 (GDF15) signaling in human airway epithelial cells. A: normal human bronchial epithelial cells transduced with lentiviruses encoding human GDF15 shRNA (shGDF15) or control shRNA (shControl) were grown at air-liquid interface and infected with HRV-16 [multiplicity of infection (MOI) 1] or PBS (control) for 24 h. A, top: quantitative Western blot densitometry data of IRF7 and β-actin protein (loading control). A, bottom: representative Western blot pictures. B, top: normal human tracheobronchial epithelial cells transduced with lentiviruses encoding human Smad1 shRNA (shSmad1) or control shRNA (shControl) were grown at air-liquid interface for 28 days to examine Smad1 protein expression. B, bottom: quantitative Western blot densitometry data of Smad1 and GAPDH protein (loading control). C: normal human tracheobronchial epithelial cells transduced with lentiviruses encoding human Smad1 shRNA (shSmad1) or control shRNA (shControl) were grown at air-liquid interface, pretreated with 0.1% BSA-HCl (control) or recombinant human GDF15 (25 ng/ml) for 72 h, and infected with HRV-16 (MOI 1) or PBS for 24 h. C, top: quantitative Western blot densitometry data of IRF7 and β-actin protein (loading control). C, bottom: representative Western blot pictures. Data are presented as means ± SE from 4 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, compared with PBS controls or shControl cells; NS, not significant.

Article Snippet: Lentiviruses encoding human Smad1 shRNA (sc-29483-v, shSmad1) or control shRNA (sc-108080, shControl) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

Techniques: Infection, Transduction, shRNA, Control, Western Blot, Expressing, Recombinant

(A) Experimental schema of blood collection during the immune process. (B) Total IgG antibody titres in the serum at 3, 14, 17, and 28 days after the first immunization (n = 6/group). (C) Serum IgG1 and IgG2/3 titres on day 28 after immunization (n = 6/group). (D) The serum samples collected after the first and second immunizations were subjected to a microneutralization assay (MAT) using 15 standard Leptospira strains, with the data limited to those strains that exhibited agglutination (n = 6/group). (B) - (D) : PBS + VAC, orally gavaged with PBS, and vaccinated; JL20 + VAC, orally gavaged with JL20, and vaccinated. Results represent mean ± SD of values. Statistical significance was evaluated using the Wilcoxon rank-sum test, with *p < 0.05, **p < 0.01, ***p < 0.001. , created in BioRender. 603, C. (2025) https://BioRender.com/4jus9df .

Journal: PLOS Neglected Tropical Diseases

Article Title: Effect of a gut commensal Lactobacillus strain Limosilactobacillus caviae JL20 on leptospiral whole-cell inactivated vaccine in hamsters

doi: 10.1371/journal.pntd.0013951

Figure Lengend Snippet: (A) Experimental schema of blood collection during the immune process. (B) Total IgG antibody titres in the serum at 3, 14, 17, and 28 days after the first immunization (n = 6/group). (C) Serum IgG1 and IgG2/3 titres on day 28 after immunization (n = 6/group). (D) The serum samples collected after the first and second immunizations were subjected to a microneutralization assay (MAT) using 15 standard Leptospira strains, with the data limited to those strains that exhibited agglutination (n = 6/group). (B) - (D) : PBS + VAC, orally gavaged with PBS, and vaccinated; JL20 + VAC, orally gavaged with JL20, and vaccinated. Results represent mean ± SD of values. Statistical significance was evaluated using the Wilcoxon rank-sum test, with *p < 0.05, **p < 0.01, ***p < 0.001. , created in BioRender. 603, C. (2025) https://BioRender.com/4jus9df .

Article Snippet: Serum samples (1:100) were added to the antigen-coated wells and incubated at 37°C for 1 h, followed by HRP conjugate secondary anti-hamster-IgG, IgG1 and IgG2/3 (1:10000) (Southernbiotech 6060-05, 1940-05, 1935-05), which was incubated for 30 minutes.

Techniques: Microneutralization Assay, Agglutination